Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

10 Hep C Stocks on Wall Street's Watch List
TheStreet.com
Thursday, September 15, 2011 - 11:58am
tags:
hepatitis C, Vertex, Merck, Anadyx, Pharmasset, Gilead, Bristol-Myers Squibb, JNJ, Medivir, Achillion, Inhibitex, Indenix
Vivus plans to resubmit potential diet pill Qnexa to FDA next month
Yahoo/AP
Thursday, September 15, 2011 - 11:52am
tags:
obesity, Vivus, FDA, Qnexa
Novo Nordisk's Data at EASD
Yahoo/Zacks.com
Thursday, September 15, 2011 - 11:51am
tags:
Novo Nordisk, diabetes, EASD, Amylin, Eli Lilly, Merck, Victoza
Pfizer Offers Investors Tremendous Upside Potential
Seeking Alpha
Thursday, September 15, 2011 - 11:50am
tags:
Pfizer, investors
GSK’s new drug marketing model: Pharma reps as educators, not sellers
Med City
Thursday, September 15, 2011 - 9:42am
tags:
GSK, drug reps
Billion Dollar Policy Ideas for Supporting Biotech Innovation
Forbes
Thursday, September 15, 2011 - 9:41am
tags:
innovation, biotech
Neglected Bacteria Give Cubist $2B Market
Bloomberg
Thursday, September 15, 2011 - 9:40am
tags:
antibiotics, Cubist Pharmaceuticals, CXA-201, gram negative bacterial infections
The Importance Of Due Diligence (Exemplified By Johnson & Johnson)
Seeking Alpha
Thursday, September 15, 2011 - 9:38am
tags:
JNJ, due diligence
J&J Pays $85M Fine Over Natrecor Marketing
Pharmalot
Wednesday, September 14, 2011 - 7:13pm
tags:
Scios, Natrecor, misbranding, JNJ, off-label
Novartis’ Pink Slip PowerPoint: CEO Plans Thousands of Layoffs
BNET Pharma
Wednesday, September 14, 2011 - 7:07pm
tags:
layoffs, Pharma CEOs, Joe Jimenez, Novartis
Pfizer Reveals How to Win Age-Bias Suits: Make Hiring as Complex as You Can
BNET Pharma
Wednesday, September 14, 2011 - 7:03pm
tags:
age discrimination, Pfizer, lawsuits
Transcept: FDA won't need new sleep-drug studies
Yahoo/AP
Wednesday, September 14, 2011 - 7:02pm
tags:
FDA, Transcept, Intermezzo
Warner Chilcott Shares Popped: What You Need to Know
Motley Fool
Wednesday, September 14, 2011 - 6:58pm
tags:
Warner Chilcott
BioSante: Study Generates Confidence For Future Treatment
Seeking Alpha
Wednesday, September 14, 2011 - 11:46am
tags:
BioSante, LibiGel, female sexual dysfunction
Healthcare's budget plan leans on Medicare beneficiaries
Fierce Pharma
Wednesday, September 14, 2011 - 11:40am
tags:
Medicare, healthcare reform
Allergan steps up Latisse testing for baldness
Fierce Pharma
Wednesday, September 14, 2011 - 11:39am
tags:
Allergan, Latisse, baldness
Why Pfizer's Earnings Are Outstanding
Motley Fool
Wednesday, September 14, 2011 - 11:37am
tags:
Pfizer, earnings
Daiichi Unit Warned By FDA Over Manufacturing
Pharmalot
Wednesday, September 14, 2011 - 11:14am
tags:
FDA, warnings, Daiichi Sankyo, Luitpold, drug manufacturing
Boston Scientific taps J&J exec as its next CEO
Reuters
Wednesday, September 14, 2011 - 11:12am
tags:
JNJ, Boston Scientific, Michael Mahoney
Naming Names: Lawmakers Tighten the Screws on Pharmaceutical Marketing
Forbes
Wednesday, September 14, 2011 - 11:09am
tags:
physician payments

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.